Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial

Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.2 to v3.5.3 in the page metadata, indicating a newer revision. This change is a metadata update and does not modify substantive content or user-facing features.
    Difference
    0.0%
    Check dated 2026-04-30T15:42:38.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:44:21.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Deleted Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T17:58:28.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the page.
    Difference
    0.0%
    Check dated 2026-03-11T15:27:33.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the content appears unchanged.
    Difference
    0.0%
    Check dated 2026-02-25T07:25:01.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and a funding-status notice along with Revision: v3.4.1 were removed. These changes are cosmetic and do not affect study details or user actions on the page.
    Difference
    0.2%
    Check dated 2026-02-11T02:05:30.000Z thumbnail image

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.